Showing 1 - 20 results of 24 for search 'W. Armstrong', query time: 0.02s Refine Results
  1. 1
    The Closing of the LSU Chemistry Library.

    The Closing of the LSU Chemistry Library. by William W. Armstrong

    Published 2005-11-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    JAK Inhibitors: Treatment Efficacy and Safety Profile in Patients with Psoriasis

    JAK Inhibitors: Treatment Efficacy and Safety Profile in Patients with Psoriasis by Leeyen Hsu, April W. Armstrong

    Published 2014-01-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Health outcome measures in atopic dermatitis: a systematic review of trends in disease severity and quality-of-life instruments 1985-2010.

    Health outcome measures in atopic dermatitis: a systematic review of trends in disease severity and quality-of-life instruments 1985-2010. by Balvinder Rehal, April W Armstrong

    Published 2011-04-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Off-label biologic regimens in psoriasis: a systematic review of efficacy and safety of dose escalation, reduction, and interrupted biologic therapy.

    Off-label biologic regimens in psoriasis: a systematic review of efficacy and safety of dose escalation, reduction, and interrupted biologic therapy. by Elizabeth A Brezinski, April W Armstrong

    Published 2012-01-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Risks to Early Childhood Health and Development in the Postconflict Transition of Northern Uganda

    Risks to Early Childhood Health and Development in the Postconflict Transition of Northern Uganda by Theresa A. McElroy, Stella Atim, Charles P. Larson, Robert W. Armstrong

    Published 2012-01-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Steroid dynamics in myalgic encephalomyelitis / chronic fatigue syndrome: a case-control study using ultra performance supercritical fluid chromatography tandem mass spectrometry

    Steroid dynamics in myalgic encephalomyelitis / chronic fatigue syndrome: a case-control study using ultra performance supercritical fluid chromatography tandem mass spectrometry by Natalie Thomas, S. J. Kumari A. Ubhayasekera, Christopher W. Armstrong, Katherine Huang, Jonas Bergquist

    Published 2025-07-01
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Implications of Extra-column Effects for Targeted or Untargeted Microflow LC-MS

    Implications of Extra-column Effects for Targeted or Untargeted Microflow LC-MS by Troy T. Handlovic, Umang Dhaubhadel, Ondřej Horáček, Martin Novák, Lucie Nováková, Daniel W. Armstrong

    Published 2025-04-01
    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    Risk assessment to Barents Sea ecosystem services: an expert-based approach

    Risk assessment to Barents Sea ecosystem services: an expert-based approach by Thuy Thi Thanh Pham, Claire W. Armstrong, Hiroko Kato Solvang, Mette Skern-Mauritzen

    Published 2025-02-01
    Get full text
    Article
    Save to List
    Saved in:
  9. 9
    Clinical Utility Findings of a Transcriptomic Psoriasis Biologic Test Demonstrate Altered Physician Prescribing Behavior and Improved Patient Outcomes

    Clinical Utility Findings of a Transcriptomic Psoriasis Biologic Test Demonstrate Altered Physician Prescribing Behavior and Improved Patient Outcomes by Bruce E. Strober, Michael Bukhalo, April W. Armstrong, David Pariser, Leon Kircik, Brian Johnson, Paul Montgomery, Tobin J. Dickerson

    Published 2025-05-01
    Get full text
    Article
    Save to List
    Saved in:
  10. 10
    Comparing antibiotic prescribing patterns for hidradenitis suppurativa between the emergency department and ambulatory care setting

    Comparing antibiotic prescribing patterns for hidradenitis suppurativa between the emergency department and ambulatory care setting by Hannah Tolson, Rebecca K. Yamamoto, Robin Kikuchi, Kaviyon Sadrolashrafi, Audrey Hao, Lily Guo, Sara Bilimoria, Danielle Yee, April W. Armstrong

    Published 2025-01-01
    Get full text
    Article
    Save to List
    Saved in:
  11. 11
    Serial Paediatrics Omics Tracking in Myalgic Encephalomyelitis (SPOT-ME): protocol paper for a multidisciplinary, observational study of clinical and biological markers of paediatric myalgic encephalomyelitis/chronic fatigue syndrome in Australian adolescents aged 12–19 years

    Serial Paediatrics Omics Tracking in Myalgic Encephalomyelitis (SPOT-ME): protocol paper for a multidisciplinary, observational study of clinical and biological markers of paediatr... by Adam Scheinberg, Natalie Thomas, Katherine Huang, Paul R Gooley, Elisha K Josev, Tracey Chau, Darcy Tantanis, Sarah J Knight, Christopher W Armstrong

    Published 2024-12-01
    Get full text
    Article
    Save to List
    Saved in:
  12. 12
    Correction: The final plague outbreak in Scotland 1644-1649: Historical, archaeological, and genetic evidence.

    Correction: The final plague outbreak in Scotland 1644-1649: Historical, archaeological, and genetic evidence. by Jenna Dittmar, Rebecca Crozier, Toni de-Dios, Christiana L Scheib, Jackson W Armstrong, Jenny Pape, Ross MacLennan, Ricky Craig, Marc Oxenham

    Published 2025-01-01
    Get full text
    Article
    Save to List
    Saved in:
  13. 13
    The impact of insurance status on psoriasis patients’ healthcare-seeking behavior: a population-based study in the United States

    The impact of insurance status on psoriasis patients’ healthcare-seeking behavior: a population-based study in the United States by Kaviyon Sadrolashrafi, Audrey Hao, Rebecca K. Yamamoto, Lily Guo, Robin Kikuchi, Hannah C. Tolson, Sara N. Bilimoria, Danielle K. Yee, April W. Armstrong

    Published 2024-11-01
    Get full text
    Article
    Save to List
    Saved in:
  14. 14
    Genotypic characterization of Egypt enterotoxigenic Escherichia coli isolates expressing coli surface antigen 6

    Genotypic characterization of Egypt enterotoxigenic Escherichia coli isolates expressing coli surface antigen 6 by Atef M El-Gendy, Adel Mansour, Hind I Shaheen, Marshall R Monteville, Adam W Armstrong, Nasr El-Sayed, Sylvia Y. N Young, John D Klena

    Published 2013-02-01
    Get full text
    Article
    Save to List
    Saved in:
  15. 15
    Assessing the adequacy of traditional hydrological models for climate change impact studies: a case for long short-term memory (LSTM) neural networks

    Assessing the adequacy of traditional hydrological models for climate change impact studies: a case for long short-term memory (LSTM) neural networks by J.-L. Martel, F. Brissette, R. Arsenault, R. Turcotte, M. Castañeda-Gonzalez, W. Armstrong, E. Mailhot, J. Pelletier-Dumont, G. Rondeau-Genesse, L.-P. Caron

    Published 2025-07-01
    Get full text
    Article
    Save to List
    Saved in:
  16. 16
    Patient-Reported Outcomes by Baseline Body Surface Area Involvement Among Individuals Initiating Biologic Therapy: Results from the CorEvitas Psoriasis Registry

    Patient-Reported Outcomes by Baseline Body Surface Area Involvement Among Individuals Initiating Biologic Therapy: Results from the CorEvitas Psoriasis Registry by April W. Armstrong, Steven R. Feldman, Timothy Fitzgerald, Theodore Alkousakis, Adam Sima, Alvin Li, Hyung-Joo Kang, Sandra I. Main, Saakshi Khattri, Linda Stein Gold

    Published 2025-06-01
    Get full text
    Article
    Save to List
    Saved in:
  17. 17
    Deucravacitinib: Laboratory Parameters Across Phase 3 Plaque Psoriasis Trials

    Deucravacitinib: Laboratory Parameters Across Phase 3 Plaque Psoriasis Trials by April W. Armstrong, Leon Kircik, Linda Stein Gold, Bruce Strober, Claudia H. M. C. De Oliveira, John Vaile, Ying-Ming Jou, Carolin Daamen, Thomas Scharnitz, Mark Lebwohl

    Published 2025-03-01
    Get full text
    Article
    Save to List
    Saved in:
  18. 18
    Tapinarof Cream for Adults and Children with Atopic Dermatitis—Efficacy by Race and Fitzpatrick Skin Type in Two Phase 3 Randomized Clinical Trials

    Tapinarof Cream for Adults and Children with Atopic Dermatitis—Efficacy by Race and Fitzpatrick Skin Type in Two Phase 3 Randomized Clinical Trials by Andrew F. Alexis, Leon Kircik, Raj Chovatiya, Zakiya P. Rice, Weily Soong, Tina Bhutani, Philip M. Brown, Stephen C. Piscitelli, David S. Rubenstein, Anna M. Tallman, April W. Armstrong

    Published 2025-07-01
    Get full text
    Article
    Save to List
    Saved in:
  19. 19
    Correction to: Deucravacitinib Improves Patient-Reported Outcomes in Patients with Moderate to Severe Psoriasis: Results from the Phase 3 Randomized POETYK PSO-1 and PSO-2 Trials

    Correction to: Deucravacitinib Improves Patient-Reported Outcomes in Patients with Moderate to Severe Psoriasis: Results from the Phase 3 Randomized POETYK PSO-1 and PSO-2 Trials by April W. Armstrong, Matthias Augustin, Jennifer L. Beaumont, Tan P. Pham, Stacie Hudgens, Kenneth B. Gordon, Joe Zhuo, Brandon Becker, Yichen Zhong, Renata M. Kisa, Subhashis Banerjee, Kim A. Papp

    Published 2025-03-01
    Get full text
    Article
    Save to List
    Saved in:
  20. 20
    Deucravacitinib Improves Patient-Reported Outcomes in Patients with Moderate to Severe Psoriasis: Results from the Phase 3 Randomized POETYK PSO-1 and PSO-2 Trials

    Deucravacitinib Improves Patient-Reported Outcomes in Patients with Moderate to Severe Psoriasis: Results from the Phase 3 Randomized POETYK PSO-1 and PSO-2 Trials by April W. Armstrong, Matthias Augustin, Jennifer L. Beaumont, Tan P. Pham, Stacie Hudgens, Kenneth B. Gordon, Joe Zhuo, Brandon Becker, Yichen Zhong, Renata M. Kisa, Subhashis Banerjee, Kim A. Papp

    Published 2024-07-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: